期刊文献+

糖基化终产物对人肾小球系膜细胞氧化应激及MCP-1表达的影响及机制 被引量:9

Effect of advanced glycosylation end products on oxidative stress and MCP-1 in human renal mesangial cells
下载PDF
导出
摘要 目的:探讨体外培养条件下糖基化终产物(AGEs)对人肾小球系膜细胞(HRMCs)中糖基化终产物受体(RAGE)、氧化应激及单核细胞趋化因子-1(MCP-1)表达的影响。方法:将HRMCs与不同浓度的糖化牛血清白蛋白(AGE-BSA)和牛血清白蛋白(BSA)共同培养,或与同一质量浓度的AGE-BSA和BSA共同培养不同时间,以中和抗RAGE抗体封闭细胞膜上RAGE;采用细胞免疫化学法检测AGEs对HRMCs中RAGE表达的影响,流式细胞术检测细胞内活性氧(ROS),半定量逆转录-聚合酶链反应(RT-PCR)法检测MCP-1 mRNA的表达。结果:在HRMCs中AGE-BSA能够促进RAGE的表达,并以时间和剂量依赖方式促进HRMCs中ROS及MCP-1的表达;ROS及MCP-1的表达水平在加入不同浓度(50、100、200、400 mg/L)的AGE-BSA作用48 h后以及加入质量浓度为200 mg/L的AGE-BSA作用不同时间(12、24、48、72 h)后,较相应质量浓度或时间的BSA组和对照组均明显升高(P<0.05);抗RAGE抗体干预后能够部分抑制AGE-BSA诱导ROS及MCP-1的表达,而人IgG没有这种作用。结论:AGEs通过RAGE激活氧化应激效应诱导MCP-1的表达上调,是糖尿病肾病发生发展的可能机制。 Objective: To investigate the effects of advanced glycosylation end products(AGEs) modified bovine serum albumin (AGE- BSA) on the expression of reactive oxygen species(ROS)and monocyte chemoauractant protein-1 (MCP-1)in human renal mesangial cells (HRMCs). Methods: HRMCs were cultured/n v/tro with medium containing different doses of AGE-BSA or BSA(50,100,200,400 mg/L)for 48 hours,or with AGE-BSA (200 rng/L) for different times (12,24,48,72 h). Immunocytochemistry assay was used to estimate the protein level of RAGE. The ROS in cells were measured by flow cytometry and the mRNA expression of MCP-1 were analyzed by semi-quantiative re- verse tmnscription-polymerase chain reaction (RT-PCR)after treatment with AGE-BSA or BSA. Results: The protein level of RAGE was up- regulated in the HRMCs with AGE-BSA . The expression of ROS and MCP-1 significantly enhanced by incubation of AGE-BSA in a time- and dose-dependent manner. The effects of AGE-BSA-induced up-regulation of ROS and MCP-1 level was significantly blocked by neutralizing anti- bodies to RAGE, while the expression of ROS and MCP-1 stood nearly unchanged after cultured with huamn IgG. Condusion: The expression of ROS and MCP-1 in HRMCs is induced by AGE-BSA through RAGE, which may have potential effects in the pathgenic mechanism of diabetic nephtopathy.
出处 《中国应用生理学杂志》 CAS CSCD 2014年第4期306-310,313,共6页 Chinese Journal of Applied Physiology
基金 福建省卫生厅青年基金项目(2012-2-27)
关键词 糖基化终产物 人肾小球系膜细胞 受体 氧化应激 单核细胞趋化因子-1 advanced glycosylafion end-products renal mesangial cells receptor oxidative stress monocyte chemoattractant protein- 1
  • 相关文献

参考文献10

  • 1张利华,张薇,韦广洪,杨沛,刘军,牛晓琳.α-亚麻酸对糖尿病大鼠炎症介质和氧化应激的影响[J].中国应用生理学杂志,2012,28(1):64-67. 被引量:16
  • 2Jiang Z,Seo JY,Ha H,et al.Reactive oxygen species me-diate TGF-betal-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells[J].Biochem Biophys Res Commun,2003,309(4):961-966.
  • 3钟林娜,黄国良,冯敏,张莹.缬沙坦对人肾小球系膜细胞糖基化终产物受体表达的影响[J].中国应用生理学杂志,2011,27(3):338-342. 被引量:3
  • 4Prodjosudjadi W,Gerritsma JS,van Es LA,et al.Monocyte chenoattractant protein-1 in normal and diseased human kid-neys:an immunohistochemical analysis [ J].Clin Nephrol,1995,44(3):148-155.
  • 5Banba N,Nakamura T,Matsumura M,et al.Possible rela-tionship of monoeyte ehem oattraetant protein-1 with diabetic ephopatby [J].Kidney Int,2000,58(2):684-690.
  • 6Segerer S,Nelson PJ,Sch]ndorff D.Chemokines,ehemokine receptors,and renal disease:from basic science to pathophysiohigic and therapeutic studies [ J ].J Am Soc Nephrol,2000,11(1):152-176.
  • 7Ha H,Yu MR,Choi YJ,et al.Role of high glucose-in-duced nuclear factor-kappaB activation in monocyte chemoat-tractant protein-1 expression by mesangial cells [ J].J Am Soc Nephrol,2002,13(4):894-902.
  • 8Yamagishi S,Inagaki Y,Okamoto T,et al.Advanced glyco-sylafion end product-inducted apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattrac-tant protein-1 in human cultured mesangial cells [ J].J Biol Chem,2002,277(23):20309-20315.
  • 9Basta G,Lazzerini G,Massaro M,et al.Advanced glycation end products activate endothelium through signal-transductionreceptor RAGE:a mechanism for amplification of inflammatory responses [J].Circulation,2002,105(7):816-822.
  • 10Twigg SM,Cao Z,MCLenna SV,et al.Renal connective tissue growth factor induction in experimental diabetes is pre-vented by aminoguanidine [J].Endocrinal,2002,143(12):4907-4915.

二级参考文献20

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:253
  • 2曾芙蓉,都健,崔丽娟.不同糖耐量状态者血清SICAM-1和SVCAM-1水平与炎症相关性研究[J].中华内分泌代谢杂志,2007,23(1):57-59. 被引量:11
  • 3Suzuki D, Toyoda M, Yamamoto N, et al. Relationship between the expression of advanced glycation end-products (AGE)and the receptor for AGE (RAGE) mRNA in diabetic nephropathy[J]. Intern Med , 2006, 45(7): 435-441.
  • 4Yu X, Li C, Li X, et al. Rosiglitazone prevents advanced glycation end products induced renal toxicity likely through suppression of plasminogen activator inhibitor- 1 [ J ]. Toxicol Sci, 21307, 96(2):346-356.
  • 5Jandeleit-Dahm K , Watson A , Soro-Paavonen A . The AGE/RAGE axis in diabetes-accelerated atherosclerosis[J]. Clin Exp Pharmacol Physiol, 2008, 35 (3) : 329-334.
  • 6Yonekura H, Yamamoto Y, Sakurai S, et al. Roles of the receptor foradvanced glycation endproducts in diabetes-induced vascular injury[J]. Pharmacol Sci, 2005, 97(3) : 305-311.
  • 7Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6): 1615-1625.
  • 8Liliensiek B, Weigand M A, Bierhaus A, et al. Receptor for advanced glycafion end products (RAGE) regulates sepsis but not the adaptive immune response[J]. Clin Invest, 2004 , 113(11) : 1641-1650.
  • 9Fan Q, Liao J, Kobayashi M, et al. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice [J]. Nephrol Dial Transplant, 2004 , 19(12): 3012-3020.
  • 10Koka V, Wang W, Huang X R, et al. Advanced glycation end products activate a chymase-dependent angiotensin Ⅱ-generating pathway in diabetic complications [J]. Circulathin, 2006, 113(10): 1353-1360.

共引文献17

同被引文献98

引证文献9

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部